Ronil A. Patel - 24 Apr 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: SVP, Operations & Bus. Dev.
Signature: /s/ Emily J. Johns, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 24 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 26 Apr 2023, 21:25:27 UTC
Next filing: 05 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+20,000	+90%	$0.000000	42,304	24 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+30,000		$0.000000	30,000	24 Apr 2023	Common Stock	30,000	$5.35	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of April 24, 2023.
F2	The option will vest with respect to 7,500 shares on April 24, 2024, with the balance vesting quarterly in twelve equal installments thereafter.